Aker BioMarine reports 17% revenue growth in 2020 amid krill EPA/DHA launch and COVID-19 hurdles

The company also entered a research collaboration for its Lysoveta krill ingredient’s potential for Alzheimer’s

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

Evonik is targeting Latin America’s “strong” market demand for dietary supplements, with the company rolling out some of its fish oil-based omega 3... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

A Bangladesh study has concluded that preventive iron treatment has no impact on young children’s development but improves anemia. These findings could inform... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Researchers in Sweden have found a positive correlation between omega 3 intake and memory in Alzheimer’s patients who performed a cognitive test. The study is... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Fatty acids are abundant in daily diets, and today, consumers are searching for more accessible ways to achieve holistic health. With this in mind, many people are... Read More

FormattedPicture

FOOD RESEARCH

Arjuna Natural’s BCM-95 turmeric extract could help to decrease damage from Alzheimer’s disease (AD) on organs other than the brain. Results showed that... Read More

trans